8-K – Page 590 – China Stock Advice

GSI [GENERAL STEEL] 8-K: General Steel Announces Expansion of Share Repurchase Program

[General Steel Announces Expansion of Share Repurchase Program Board of Directors Authorizes Purchase of Additional One Million Shares Following Completion of Initial Buyback BEIJING -- June 1, 2011 -- General Steel Holdings, Inc. ("General Steel" or "the Company") (NYSE: GSI), one of China's leading non-state-owned producers of steel products and aggregators of domestic steel companies, today announced that its Board] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): June 1, 2011 General Steel Holdings, Inc. Nevada 001-33717 41-2079252 (State or other jurisdiction of incorporation) (IRS Employer Identification Number) Suite 2315, Kun Tai International Mansion Building, Yi No. 12, Chaoyangmenwai Ave., Chaoyang District, Beijing 100020 + 86 (10) 58797346 (Former name or former address, if changed since]

By info| 2016-03-14T16:30:14+00:00 June 3rd, 2011|Categories: Chinese Stocks, GSI, Webplus ver|Tags: 0001239188, 2011-06-03, 3310, 8-K, GSI, STEEL WORKS, BLAST FURNACES and ROLLING and FINISHING MILLS|0 Comments

CXDC [China XD Plastics Co] 8-K: (Original Filing)

[China XD Plastics Board of Directors Approves Construction Plan and Construction Budget of the New Facility and the Construction Project Cooperation Agreement HARBIN, China, June 2, 2011 CXDC According to the construction project cooperation agreement, Harbin Xinda intends to commission Harbin Shengtong to build the 5 plants and new R&D Center based on the recent land purchase of nearly 50] [厂房及研发实验楼项目建设合作协议书 Factory and R&D Laboratory Buildings Construction Project Cooperation Agreement “ ” _2011_ _6_ _1_ 本合作协议书（ June, 2011, The Cooperation Agreement (this “Agreement”) is made and entered into by and between the Parties below as of the 1st day of 甲方： Party A: Harbin Xinda Macromolecule Material Co., Ltd. 地址： Address: 乙方： Party B: Harbin Shengtong Engineering Plastics Co., Ltd.] []

By info| 2016-03-25T17:19:45+00:00 June 3rd, 2011|Categories: Chinese Stocks, CXDC, SEC Original|Tags: 0001353970, 2011-06-03, 3086, 8-K, CXDC, PLASTICS FOAM PRODUCTS|0 Comments

CXDC [China XD Plastics Co] 8-K: China XD Plastics Board of Directors Approves Construction

[China XD Plastics Board of Directors Approves Construction Plan and Construction Budget of the New Facility and the Construction Project Cooperation Agreement HARBIN, China, June 2, 2011 CXDC According to the construction project cooperation agreement, Harbin Xinda intends to commission Harbin Shengtong to build the 5 plants and new R&D Center based on the recent land purchase of nearly 50] [厂房及研发实验楼项目建设合作协议书 Factory and R&D Laboratory Buildings Construction Project Cooperation Agreement “ ” _2011_ _6_ _1_ 本合作协议书（ June, 2011, The Cooperation Agreement (this “Agreement”) is made and entered into by and between the Parties below as of the 1st day of 甲方： Party A: Harbin Xinda Macromolecule Material Co., Ltd. 地址： Address: 乙方： Party B: Harbin Shengtong Engineering Plastics Co., Ltd.] []

By info| 2016-03-25T17:21:10+00:00 June 3rd, 2011|Categories: Chinese Stocks, CXDC, Webplus ver|Tags: 0001353970, 2011-06-03, 3086, 8-K, CXDC, PLASTICS FOAM PRODUCTS|0 Comments

SCOK [Hongli Clean Energy Technologies] 8-K: (Original Filing)

[May 31, 2011 Dear Mr. Jianhua Lv and Board Members: It is with mixed feelings that I hereby resign my positions of Vice Chairman, Secretary and the Board of the Directors of Sinocoking Coal and Chemical Industries Inc. effective immediately. I want to express my appreciation to all of your management team for the dedication and effort to move the] [May 31, 2011 Mr. Jianhua Lv Chairman, Board of Directors Sinocoking Coal & Coke Chemical Industries, Inc. Kuanggong Road and Tiyu Road 10th Floor, Chengshi Xin Yong She, Tiyu Road, Xinhua District, Pingdingshan, Henan Province, Peoples’ Republic of China 467000 Dear Chairman Lv: Effective as of May 31, 2011, I resign from all my positions held with Sinocoking Coal &] [Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers.]

By info| 2016-03-30T09:23:33+00:00 June 3rd, 2011|Categories: Chinese Stocks, SCOK, SEC Original|Tags: 0001099290, 2011-06-03, 3312, 8-K, SCOK, STEEL WORKS, BLAST FURNACES ROLLING MILLS (COKE OVENS)|0 Comments

ONP [Orient Paper] 8-K: (Original Filing)

[Orient Paper Engages BDO Limited to Re-Audit Fiscal Year 2008 Financial Results Orient Paper, Inc. ONP News BAODING, China, May 31, 2011 /PRNewswire-Asia/ -- As previously announced, due to lapsed licenses of Orient Paper's previous audit firm, Davis Accounting Group P.C. ("Davis Accounting"), at the time of auditing the Company's FY 2008 financial statements, the Company's FY 2008 financial statements] [Item 8.01. Other Events.]

By info| 2016-03-20T00:39:20+00:00 June 2nd, 2011|Categories: Chinese Stocks, ONP, SEC Original|Tags: 0001358190, 2011-06-02, 2670, 8-K, CONVERTED PAPER and PAPERBOARD PRODS (NO CONTAINERS/BOXES), ONP|0 Comments

ONP [Orient Paper] 8-K: Orient Paper Engages BDO Limited to Re-Audit Fiscal

[Orient Paper Engages BDO Limited to Re-Audit Fiscal Year 2008 Financial Results Orient Paper, Inc. ONP News BAODING, China, May 31, 2011 /PRNewswire-Asia/ -- As previously announced, due to lapsed licenses of Orient Paper's previous audit firm, Davis Accounting Group P.C. ("Davis Accounting"), at the time of auditing the Company's FY 2008 financial statements, the Company's FY 2008 financial statements] [Item 8.01. Other Events.]

By info| 2016-03-20T00:40:33+00:00 June 2nd, 2011|Categories: Chinese Stocks, ONP, Webplus ver|Tags: 0001358190, 2011-06-02, 2670, 8-K, CONVERTED PAPER and PAPERBOARD PRODS (NO CONTAINERS/BOXES), ONP|0 Comments

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[FORM OF RESTRICTED SHARE AWARD AGREEMENT 2010 LONG-TERM INCENTIVE PLAN OF CHINA PHARMA HOLDINGS, INC. * * * * * Participant: _______ Number of Restricted Shares granted: _______ * * * * * 1. Incorporation By Reference; Plan Document Receipt . 2. Grant of Restricted Share Award . Vesting 3.1 · _______________________________________ 3.2 3.3 If the Participant’s employment with the] [FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT 2010 LONG-TERM INCENTIVE PLAN OF CHINA PHARMA HOLDINGS, INC * * * * * Optionee: ________ Per Share Exercise Price: $________ Number of Option Shares subject to this Option: ________ * * * * * 1. Incorporation By Reference; Plan Document Receipt . 2. Grant of Option . 3. No Dividends Equivalents . 4.] [EMPLOYMENT AGREEMENT 聘用协议 May 31 Agreement Company nd Employee ### ## #### Parties This EMPLOYMENT AGREEMENT is made and entered into on — 17 2 570216 ### ## #### 2011-5- 31. 这份协议是由中国医药控股有限公司（“公司”） WITNESSETH: 条款 WHEREAS, the Company is engaged in the business of develop, manufacture, and market specialty pharmaceutical products in China (the “business”); and 鉴于，公司是一家在中国从事研发，生产，销售的专业的制药企业。并且 WHEREAS, Employee has represented]

By info| 2016-03-03T19:28:25+00:00 June 1st, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 2011-06-01, 2834, 8-K, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 8-K: FORM OF RESTRICTED SHARE AWARD AGREEMENT 2010 LONG-TERM

[FORM OF RESTRICTED SHARE AWARD AGREEMENT 2010 LONG-TERM INCENTIVE PLAN OF CHINA PHARMA HOLDINGS, INC. * * * * * Participant: _______ Number of Restricted Shares granted: _______ * * * * * 1. Incorporation By Reference; Plan Document Receipt . 2. Grant of Restricted Share Award . Vesting 3.1 · _______________________________________ 3.2 3.3 If the Participant’s employment with the] [FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT 2010 LONG-TERM INCENTIVE PLAN OF CHINA PHARMA HOLDINGS, INC * * * * * Optionee: ________ Per Share Exercise Price: $________ Number of Option Shares subject to this Option: ________ * * * * * 1. Incorporation By Reference; Plan Document Receipt . 2. Grant of Option . 3. No Dividends Equivalents . 4.] [EMPLOYMENT AGREEMENT 聘用协议 May 31 Agreement Company nd Employee ### ## #### Parties This EMPLOYMENT AGREEMENT is made and entered into on — 17 2 570216 ### ## #### 2011-5- 31. 这份协议是由中国医药控股有限公司（“公司”） WITNESSETH: 条款 WHEREAS, the Company is engaged in the business of develop, manufacture, and market specialty pharmaceutical products in China (the “business”); and 鉴于，公司是一家在中国从事研发，生产，销售的专业的制药企业。并且 WHEREAS, Employee has represented]

By info| 2016-03-03T19:29:30+00:00 June 1st, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 2011-06-01, 2834, 8-K, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[FORM OF RESTRICTED SHARE AWARDREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Participant: _______ Number of Restricted Shares granted:_______ ***** 2. Grant of Restricted Share Award . Vesting 3.1 _______________________________________ 3.3 If the Participants employment with thempany and/or its Subsidiaries terminates due to the Participant's death, Disability or Retirement, the Participant shall become 100% vested] [FORM OF NON-QUALIFIED STOCK OPTIONREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Optionee:________ Per Share Exercise Price: $________ Number of Option Shares subject to this Option: ________ ***** 2. Grant of Option . 3. No Dividends Equivalents . 4. Exercise of this Option . 4.1 4.2 4.3] [EMPLOYMENTREEMENT WITNESSETH: WHEREAS, thempany is engaged in the business of develop, manufacture, and marketecialty pharmaceutical products in China (the business); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable him to be thempanys Chief Financial Officer; and WHEREAS, based on such representation, and thempanys reasonable due diligence, thempany]

By info| 2016-02-07T22:57:57+00:00 June 1st, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 2011-06-01, 2834, 8-K, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 8-K: FORM OF RESTRICTED SHARE AWARDREEMENT 2010 LONG-TERMENTIVE PLAN

[FORM OF RESTRICTED SHARE AWARDREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Participant: _______ Number of Restricted Shares granted:_______ ***** 2. Grant of Restricted Share Award . Vesting 3.1 _______________________________________ 3.3 If the Participants employment with thempany and/or its Subsidiaries terminates due to the Participant's death, Disability or Retirement, the Participant shall become 100% vested] [FORM OF NON-QUALIFIED STOCK OPTIONREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Optionee:________ Per Share Exercise Price: $________ Number of Option Shares subject to this Option: ________ ***** 2. Grant of Option . 3. No Dividends Equivalents . 4. Exercise of this Option . 4.1 4.2 4.3] [EMPLOYMENTREEMENT WITNESSETH: WHEREAS, thempany is engaged in the business of develop, manufacture, and marketecialty pharmaceutical products in China (the business); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable him to be thempanys Chief Financial Officer; and WHEREAS, based on such representation, and thempanys reasonable due diligence, thempany]

By info| 2016-02-07T22:58:51+00:00 June 1st, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 2011-06-01, 2834, 8-K, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments